- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Organ-on-a-chip models for development of cancer immunotherapies ; volume:72 ; number:12 ; day:3 ; month:11 ; year:2023 ; pages:3971-3983 ; date:12.2023
Cancer immunology immunotherapy ; 72, Heft 12 (3.11.2023), 3971-3983, 12.2023
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-023-03572-7
- URN
-
urn:nbn:de:101:1-2024022307483416279927
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chernyavska, M.
- Masoudnia, M.
- Valerius, Thomas
- Verdurmen, W. P. R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neurotoxicity of novel cancer immunotherapies
Advances in Prostate Cancer Immunotherapies
Implantable Biomaterials for Cancer Immunotherapies
Development of NK cell-based cancer immunotherapies through receptor engineering
Computational methods to improve development of T cell based cancer immunotherapies
Clinical landscape of macrophage-reprogramming cancer immunotherapies
Cancer immunotherapies targeting the PD-1 signaling pathway
Revolutionizing cancer treatment: the rise of personalized immunotherapies
Immersion in the search for effective cancer immunotherapies
Immunotherapies for pediatric cancer: current landscape and future perspectives
Nanotechnology‐Empowered Combination Cancer Immunotherapies: Mechanisms, Synergies, and Perspectives
Immunotherapies in solid tumors
Neurotoxicity of novel cancer immunotherapies
Advances in Prostate Cancer Immunotherapies
Implantable Biomaterials for Cancer Immunotherapies
Development of NK cell-based cancer immunotherapies through receptor engineering
Computational methods to improve development of T cell based cancer immunotherapies
Clinical landscape of macrophage-reprogramming cancer immunotherapies
Cancer immunotherapies targeting the PD-1 signaling pathway
Revolutionizing cancer treatment: the rise of personalized immunotherapies
Immersion in the search for effective cancer immunotherapies
Immunotherapies for pediatric cancer: current landscape and future perspectives
Nanotechnology‐Empowered Combination Cancer Immunotherapies: Mechanisms, Synergies, and Perspectives
Immunotherapies in solid tumors
Neurotoxicity of novel cancer immunotherapies
Advances in Prostate Cancer Immunotherapies
Implantable Biomaterials for Cancer Immunotherapies
Development of NK cell-based cancer immunotherapies through receptor engineering
Computational methods to improve development of T cell based cancer immunotherapies
Clinical landscape of macrophage-reprogramming cancer immunotherapies
Cancer immunotherapies targeting the PD-1 signaling pathway
Revolutionizing cancer treatment: the rise of personalized immunotherapies
Immersion in the search for effective cancer immunotherapies
Immunotherapies for pediatric cancer: current landscape and future perspectives
Nanotechnology‐Empowered Combination Cancer Immunotherapies: Mechanisms, Synergies, and Perspectives